Hims & Hers Health: Capitalizing On Healthcare Innovation (NYSE:HIMS)

I gave Hims & Hers Health, Inc. (NYSE: HIMS ) a buy rating in my second article on the company on March 25, 2025. As the following chart shows, the stock has been extraordinarily volatile since that recommendation.I have been a Merchant Seaman that has traveled the world for over 30 years. Within the last 15 years, I developed a very intense interest in investing. I learned a lot of what I know about investing from The MF. Also because I have a engineering background, I often tend to gravitate to Tech stock ...